Typewriter Therapeutics, Inc., 2026-09-21
An SEC Form D private-offering notice from Cambridge, MA, a $56,299,999 filer-stated offering target in Biotech. Filed 2026-09-21. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Develops all-RNA genetic medicines using RNA-delivered gene insertion technology for in vivo CAR-T and liver-targeted therapies
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- AutoIVF, Inc., 2026-09-25, $1.5M, Natick, MA
- Biophytis SA, 2026-09-23, $2.6M, Paris
- BorderLogic Inc., 2026-09-23, $5.5M, Boston, MA
- Navion Neurosciences Inc., 2026-09-22, $5.1M, Charlottesville, VA
- Bay State Marine Electric Corp, 2026-09-22, $150K, Boston, MA
- Opus Medical Therapies, LLC, 2026-09-22, Smyrna, GA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.